Search Results - Arthur Liu

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Hypoxia-activated prodrug and antiangiogenic therapies cooperatively treat pancreatic cancer but elicit immunosuppressive G-MDSC infiltration by Arthur Liu, Seth T. Gammon, Federica Pisaneschi, Akash Boda, Casey R. Ager, David Piwnica-Worms, David S. Hong, Michael A. Curran

    Published in JCI Insight (2024-01-01)
    Get full text
    Article


  2. 2

    Type I MET inhibitors cooperate with PD-1 blockade to promote rejection of hepatocellular carcinoma by Michael A Curran, Joanna Schmidt, Ahmed O Kaseb, Arthur Liu, Madeline Steiner, Ricardo DeAzevedo, Broderick X Turner, Sherwin Newton, Rachel Fleming, Angelica Tolentino

    Published in Journal for ImmunoTherapy of Cancer (2024-10-01)
    Get full text
    Article


  3. 3

    Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma by Stephen M.F. Jamieson, Peter Tsai, Maria K. Kondratyev, Pratha Budhani, Arthur Liu, Neil N. Senzer, E. Gabriela Chiorean, Shadia I. Jalal, John J. Nemunaitis, Dennis Kee, Avik Shome, Way W. Wong, Dan Li, Nooriyah Poonawala-Lohani, Purvi M. Kakadia, Nicholas S. Knowlton, Courtney R.H. Lynch, Cho R. Hong, Tet Woo Lee, Reidar A. Grénman, Laura Caporiccio, Trevor D. McKee, Mark Zaidi, Sehrish Butt, Andrew M.J. Macann, Nicholas P. McIvor, John M. Chaplin, Kevin O. Hicks, Stefan K. Bohlander, Bradly G. Wouters, Charles P. Hart, Cristin G. Print, William R. Wilson, Michael A. Curran, Francis W. Hunter

    Published in JCI Insight (2023-02-01)
    Get full text
    Article


Search Tools: